Case Studies in Ovarian Cancer Vol. 3, No. 1 |
|
- Management of Platinum-Resistant Ovarian Cancer
1 AMA PRA Category 1 CreditTM
Expiration date: June 06, 2009 |
Targeted Therapies in Oncology Vol. 6 No. 2 |
|
- The Extrinsic Pathway: Targeting Death Receptors in Cancer Therapy
- Targeting the Cell Cycle and DNA Repair Machinery for Cancer Therapy
1 AMA PRA Category 1 CreditTM
Expiration date: March 03, 2009 |
Monographs in Hepatocellular Carcinoma |
|
- Current Perspectives: Etiology and Molecular Pathogenesis of Hepatocellular Carcinoma
- Targeted Therapy for Hepatocellular Carcinoma: Overview of Current and Future Trials
- Treatment Approaches for Localized Hepatocellular Carcinoma
1 AMA PRA Category 1 CreditTM
Expiration date: December 14, 2008 |
Angiogenesis in Oncology Vol. 2, No. 5 |
|
- Incorporating Antiangiogenic Agents Into the Perioperative Setting
for Colorectal Cancer
- Biology and Management of Hypertension and Other Class-Effect
Toxicities Related to Antiangiogenic Therapy
- Novel Avenues in Antivascular Tumor Therapy
1 AMA PRA Category 1 CreditTM
Expiration date: December 7, 2008 |
Targeting Therapies in Oncology Vol. 6, No. 1 |
|
- Novel Strategies for Treating Ovarian Cancer
- Emerging Monoclonal Antibodies for the Treatment of HER2-Positive Breast Cancer
1 AMA PRA Category 1 CreditTM
Expiration date: December 7, 2008 |
Emerging Pathways With Therapeutic Potential in Cancer |
|
- Targeting Signaling Pathways to Inhibit Cancer Growth
- Targeting the MAP/MEK and PI3K/Akt Pathways
- Novel Small-Molecular Inhibitors Targeting VEGFR in Breast Cancer
- Vaccines in Lung Cancer
- Novel Immunologic Targets in Metastatic Melanoma
- Combining Targeted Agents to Improve Therapeutic Efficacy
1 AMA PRA Category 1 CreditTM
Expiration date: November 20, 2008 |
| Translating the Complexities of Cancer Development Into Novel Therapeutics |
|
- Combining VEGF and EGFR Inhibition in NSCLC
- Second-Generation Inhibitors of the VEGFR Tyrosine Kinase
- Small-Molecule TKIs in the Treatment of Advanced Thyroid Cancer
- Harnessing SPARC Protein for Uptake of Chemotherapy in Tumors
- Current Data on Raf/MEK Inhibitors in Melanoma and Other Cancers
- Understanding the Kinome and Its Role in Cancer Pathogenesis
1 AMA PRA Category 1 Credit™
Expiration date: November 20, 2008
|
| Advances in Pancreatic Cancer Vol. 1, No. 1 |
|
- Recent Data on Resectable Pancreatic Cancer
- Antiangiogenic Therapies in Pancreatic Cancer
- EGFR-Targeted Therapies in Pancreatic Cancer
1 AMA PRA Category 1 Credit™
Expiration date: October 31, 2008
|
| The Interface Between Molecular Biology and Clinical Practice: Targeting the Ras/Raf Signaling Network in Cancer |
|
- Efficacy of Biologic Targeted Agents in Hepatocellular Carcinoma
- Antiangiogenic Agents in NSCLC
- Beyond Proof of Principle for Multikinase Inhibitors in Renal Cell Carcinoma
- Update on Therapeutic Inhibition of Raf in Metastatic Melanoma
1 AMA PRA Category 1 Credit™
Expiration date: October 31, 2008
|
| Oncology Consultations Vol. 4, No. 8 |
|
- Advances in Hepatocellular Carcinoma
1 AMA PRA Category 1 Credit™
Expiration date: October 31, 2008
|
| Oncology Briefings Vol. 5, No. 5 |
|
- Oncology Briefings
Novel Agents in Metastatic Melanoma
0.5 AMA PRA Category 1 Credit™
Expiration date: October 22, 2008
|
| Oncology Briefings Vol. 5, No. 6 |
|
- Adjuvant TKI Therapy in GIST
0.5 AMA PRA Category 1 Credit™
Expiration date: October 15, 2008
|
| Case Studies in Oncology Vol. 8, No. 7 |
|
- Neoadjuvant Imatinib for Primary Localized GIST
1 AMA PRA Category 1 Credit™
Expiration date: September 30, 2008
|
| Case Studies in Pain Management Vol. 1, No. 2 |
|
- Ziconotide for Pain From MBC
1 AMA PRA Category 1 Credit™
Expiration date: September 30, 2008
|
